Atlas Trials

Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging

Clinical trial NCT04776187 · UNKNOWN

Trial details

NCT number
NCT04776187
Sponsor
The Central Hospital of Lishui City
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Nephrogenic Fibrosing Dermopathy
Start date
2021-03-01
Primary completion
2021-12-31
Enrollment
600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.